Skip to main content
18 February 2019
Last updated:
Monday 18 February 2019

User account menu

  • Log in
  • Register & Subscribe

Search this site:

 

Primary links

  • Home
  • News
  • About MedNous
  • Research Directory
  • Contact Us

GW Pharma raises $300 million on Nasdaq

Wednesday 3 October 2018
Country

United Kingdom

GW Pharmaceuticals Plc has raised $300 million in a secondary offering on the US Nasdaq, providing it with capital to commercialise its recently approved cannabinoid medicine Epidiolex for the treatment of seizures associated with t

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Company News
Finance, Grants, Deals

Select a News Category

  • Clinical Research
  • Company News
  • Finance, Grants, Deals
  • IPR & Legal
  • Regenerative Medicine
  • Regulation & Policy
  • Research & University News

Recent Appointments

Donato Spota to become CFO at Hansa Biopharma
Thursday February 7 2019
Georgia Gavriilidou joins Sidley Austin
Thursday February 7 2019
Alan Knox becomes CEO at Primex
Thursday February 7 2019
Kiadis appoints Robert Friesen as CSO
Thursday February 7 2019
Samantha Paston to head research at Scancell
Thursday February 7 2019

© 2018 Evernow Publishing Ltd. Powered by Drupal.